This study will be an initial proof of concept study, to evaluate safety and efficacy of a prototype suprachoroidal retinal implant
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
3
Manufacturer = Bionics Institute, Australia
Nicta / Data61
Canberra, Australian Capital Territory, Australia
Centre for Eye Research Australia
East Melbourne, Victoria, Australia
Safety
Number of device-related serious adverse events
Time frame: 18 months
Ability to perceive visual percepts during device stimulation
Number of participants able to perceive phosphenes when the device is stimulated
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.